Āé¶¹“«Ć½

Clue to treatments for fatal Huntington’s

The genetic defect behind the incurable brain disease causes malfunctions in mitochondria, US research shows

The genetic defect behind Huntington’s disease causes malfunctions in mitochondria, the energy-producing components of cells, new work shows. The finding should help explain how the mutation causes the disease and could lead to new approaches to treatment.

Since 1993, researchers have known that Huntington’s – an incurable and fatal brain disorder – is caused by a defect in a single gene that encodes a protein called huntingtin.

They have also long suspected that some of the symptoms of the disorder are due to defects in mitochondria. Now, for the first time, a team led by Alexander Panov at Emory University, US, have directly linked the two.

Panov’s work suggests that huntingtin kills brain cells, at least in part, by causing mitochondria in the cells to respond abnormally to a type of chemical stress. This causes the mitochondria to spill some of their contents. And this could cause cell death, Panov thinks.

ā€œThis study brings together several lines of research,ā€ says Elena Cattaneo, a pharmacologist at the University of Milan. ā€œIt shows how the mitochondria are linked to the toxicity of the mutant gene.ā€

New drugs

Panov’s team examined mitochondria from blood cells of patients with Huntington’s disease and from brain cells of engineered mice that produce mutant huntingtin. They found that these mitochondria could not handle a certain kind of stress caused by calcium as well as normal mitochondria.

The researchers also found that mutant huntingtin can bind directly to normal mitochondria and cause them to respond abnormally to calcium-induced stress. This ā€œstressā€ happens during part of the normal signalling process in the brain.

Cattaneo believes the finding could lead to new drugs that would alleviate some of the symptoms of the disorder by correcting the defective mitochondria. ā€œThis may really open up some new perspectives for treating Huntington’s disease,ā€ she says.

But M. Flint Beal, a neuroscientist at Cornell University, believes that more experiments must be done to determine whether the mitochondrial defect that Panov has observed really causes Huntington’s disease.

Other factors

ā€œI’m not entirely sure that this is the whole story in the living person,ā€ he argues. ā€œThey haven’t proven that this [mitochondrial defect] causes what happens in patients.ā€

Panov agrees that mutant huntingtin might cause cell death and disease by affecting other factors besides the mitochondria.

ā€œWhat I’ve discovered is one mechanism,ā€ he admits. ā€œBut it’s probably not the only one.ā€

Huntington’s disease affects one in 10,000 people. A child of a sufferer has a 50 per cent chance of developing the disease. Journal reference: Nature Neuroscience (DOI: 10.1038/nn884)